Oda Nobuhiro, Matsui Hiroki, Hazue Ryo, Matsue Kosei, Takagishi Katsushige, Rokutanda Ryo
Department of Rheumatology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Mod Rheumatol. 2025 Jul 5;35(4):731-737. doi: 10.1093/mr/roaf009.
To investigate the factors affecting laboratory data and computed tomography (CT) attenuation values of L1 trabecular and femoral bone marrow, potential markers for differentiating between adult-onset Still's disease (AOSD) and intravascular large B-cell lymphoma (IVLBL).
We conducted a retrospective observational study on patients diagnosed with AOSD or IVLBCL. Clinical and laboratory data, and CT attenuation values of the bone marrow were compared. An exploratory analysis was conducted to identify factors useful for discriminating between the two groups.
Thirty patients with AOSD and 14 with IVLBCL were included; among them, 17 and 14 patients, respectively, underwent plain CT. No significant differences in CT attenuation values were noted; however, significant differences in various clinical and laboratory data, including neutrophil counts and soluble interleukin 2 receptor levels, were observed. Exploratory analysis of the monocyte fraction, guided by previous reports, suggested a cutoff of ≥ 9.65% for IVLBCL, with a sensitivity of 64.3% and specificity of 96.7%.
This study suggests that, besides neutrophil counts and soluble interleukin 2 receptor levels, monocyte fractionation is a useful differentiation criterion between AOSD and IVLBCL.
研究影响L1小梁和股骨骨髓实验室数据及计算机断层扫描(CT)衰减值的因素,这些因素是区分成人斯蒂尔病(AOSD)和血管内大B细胞淋巴瘤(IVLBL)的潜在标志物。
我们对诊断为AOSD或IVLBCL的患者进行了一项回顾性观察研究。比较了临床和实验室数据以及骨髓的CT衰减值。进行了探索性分析以确定有助于区分两组的因素。
纳入30例AOSD患者和14例IVLBCL患者;其中分别有17例和14例患者接受了平扫CT检查。未发现CT衰减值有显著差异;然而,观察到包括中性粒细胞计数和可溶性白细胞介素2受体水平在内的各种临床和实验室数据存在显著差异。根据先前的报告对单核细胞比例进行的探索性分析表明,IVLBCL的临界值为≥9.65%,敏感性为64.3%,特异性为96.7%。
本研究表明,除中性粒细胞计数和可溶性白细胞介素2受体水平外,单核细胞分级是AOSD和IVLBCL之间有用的鉴别标准。